CELLINO
Live / Allowed — Fourth extension granted (statement of use) (as of 30 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 07 Apr 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97877412
- Mark type
- Word mark
- Filed
- 07 Apr 2023
- Published for opposition
- 13 Feb 2024
- Attorney of record
- John L. Slafsky
Goods and services
- Class 001 — Chemicals: Stem cells for research purposes
- Class 005 — Pharmaceuticals: Stem cells for medical purposes
- Class 042 — Scientific and technological services: Research and development of personalized, stem cell-based medicines; Technological consulting for manufacturing processes in the biotechnology industry
- Class 044 — Medical, beauty and agricultural services: Medical services in the nature of assisting or developing stem-cell therapy plans for others; medical services relating to the manufacture, differentiation, treatment and/or processing of stem cells
Owner
- Cellino Biotech, Inc., Cambridge, MA, US
- Cellino Biotech, Inc., Cambridge, MA, US
Prosecution history
- 01 Sept 2026 — TEAS STATEMENT OF USE RECEIVED
- 01 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2026 — SOU EXTENSION 4 GRANTED
- 30 Mar 2026 — SOU EXTENSION 4 FILED
- 30 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 3 GRANTED
- 30 Sept 2025 — SOU EXTENSION 3 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 02 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Apr 2025 — SOU EXTENSION 2 GRANTED
- 01 Apr 2025 — SOU EXTENSION 2 FILED
- 01 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Sept 2024 — SOU EXTENSION 1 GRANTED